• Follow
  • Follow
  • Menu Item

Log in

Subscribe Today
G2 Intelligence
  • Industry Perspectives
  • Industry News
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Subscriber Articles
    • Editor Exclusives
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LAB INDUSTRY REPORT

NATIONAL LAB REPORTER

Eight Charged in Alleged $150M Crestar Labs Fraud Scheme

Eight Charged in Alleged $150M Crestar Labs Fraud Scheme

by Rachel Muenz | Aug 10, 2022 | News

Individuals were supposedly paid kickbacks to obtain genetic samples for unnecessary genetic testing, which was then falsely billed to federal healthcare programs.

Pharmacy Settles Prior Authorization Fraud Allegations for $115,000

Pharmacy Settles Prior Authorization Fraud Allegations for $115,000

by Rachel Muenz | Aug 3, 2022 | News

New York-based specialty pharmacy allegedly altered documentation, including lab test results, to obtain insurance coverage of expensive drug.

Compliance Lessons for Labs Following Massive Takedown

Compliance Lessons for Labs Following Massive Takedown

by Rachel Muenz | Aug 3, 2022 | News

Here are some steps labs may want to take in the wake of the 2022 National Health Care Fraud Enforcement Action.

Labs on Notice Following Healthcare Fraud Enforcement Action

Labs on Notice Following Healthcare Fraud Enforcement Action

by Rachel Muenz | Jul 29, 2022 | Compliance Perspectives-lca, Editor Exclusives, Lab Compliance Advisor

Danielle H. Tangorre discusses key takeaways for labs from the DOJ’s recent nationwide takedown of $1.2 billion in alleged schemes.

This content is for Paid Members only.
Login Join Now
Nationwide Takedown Headlines Busy Enforcement Week

Nationwide Takedown Headlines Busy Enforcement Week

by Rachel Muenz | Jul 27, 2022 | News

Last week saw a takedown of $1.2B worth of alleged fraud schemes involving labs, genetic testing, and telemedicine.

« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Privacy Policy
  • Terms
  • About Us
    • G2 Intelligence Team
    • Contact Us
  • Homepage
  • FAQ
Copyright © 2022 G2 Intelligence.com